Video blog: HER2-targeted agents

Removing more lymph nodes during surgery may also increase the risk for death after surgery in muscle-invasive bladder cancer.

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.

After my surgery for testicular cancer, my good friend Joe helped me through my goal of training and running a marathon.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

While being a caregiver to my youngest daughter with brain cancer, I felt emotional turmoil while being away from my firstborn daughter.

The Food and Drug Administration (FDA) has approved Itovebi (inavolisib) with Ibrance (palbociclib) and Faslodex (fulvestrant) for certain patients with advanced or metastatic breast cancer.